Terry Fullem is the President of Strides Pharma Inc., the U.S. subsidiary of Strides Pharma Science Limited. He is responsible for the business operations of Strides entities in the U.S.

Terry has over 25 years of experience in the pharmaceutical industry, including generics and brands. Prior to joining Strides, he was the President at Jubilant Cadista; and he has previously worked at Perrigo and Actavis. His experience crosses generics, OTC and branded medicines and he has led acquisitions, started green field operations, and enhanced processes to grow topline revenues and achieve significant cost savings.

His career prior to pharmaceuticals included working with Fortune 50 companies across a variety of industries, as a strategy consultant for Mars & Co.

Terry holds a BA in Economics from Colgate University and an MBA with emphases in Finance, Management and Marketing from the Stern School of Business.